- Renovaro (NASDAQ:RENB) said on Monday that it has entered into a binding LOI to acquire Predictive Oncology (NASDAQ:CIRCLE) in the transaction of all shares.
- The company said “the acquisition provides access to critical resources that include a biobank of more than 150,000 tumor samples, 200,000 pathology slides and decades of longitudinal drug response data.”
- CIRCLE +5.0% premarket at $1.26.
- Source: Press release